ENALAPRIL IN ESSENTIAL-HYPERTENSION - A COMPARATIVE-STUDY WITH PROPRANOLOL

被引:0
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:51 / 56
页数:6
相关论文
共 11 条
[1]  
BAI TR, 1982, J ROY COLL PHYS LOND, V16, P239
[2]   ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].
BIOLLAZ, J ;
SCHELLING, JL ;
COMBES, BJD ;
BRUNNER, DB ;
DESPONDS, G ;
BRUNNER, HR ;
ULM, EH ;
HICHENS, M ;
GOMEZ, HJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368
[3]   EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].
BRUNNER, DB ;
DESPONDS, G ;
BIOLLAZ, J ;
KELLER, I ;
FERBER, F ;
GAVRAS, H ;
BRUNNER, HR ;
SCHELLING, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467
[4]   EFFECTS OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, IN HYPERTENSION [J].
FERGUSON, RK ;
VLASSES, PH ;
SWANSON, BN ;
MOJAVERIAN, P ;
HICHENS, M ;
IRVIN, JD ;
HUBER, PB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :48-53
[5]  
FERGUSON RK, 1983, CLIN PHARMACOL THER, V33, P254
[6]  
GAVRAS H, 1981, LANCET, V2, P543
[7]   CAPTOPRIL - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY [J].
HEEL, RC ;
BROGDEN, RN ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1980, 20 (06) :409-452
[8]  
JACKSON B, 1982, CLIN EXP PHARM PHY S, V7, P99
[9]   PHARMACODYNAMICS OF CONVERTING ENZYME-INHIBITION - THE CARDIOVASCULAR, ENDOCRINE AND AUTONOMIC EFFECTS OF MK421 (ENALAPRIL) AND MK521 [J].
MILLAR, JA ;
DERKX, FHM ;
MCLEAN, K ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :347-355
[10]  
TOCCO DJ, 1982, DRUG METAB DISPOS, V10, P15